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Arterio-venous metabolomics 
exploration reveals major changes 
across liver and intestine in the 
obese Yucatan minipig
nathalie poupin  2, Marie tremblay-franco2,4, Aurélien Amiel2,4, cécile canlet2,4, 
Didier Rémond1, Laurent Debrauwer2,4, Dominique Dardevet1, ines thiele3,5,6, 
Maike K. Aurich3, fabien Jourdan2, isabelle Savary-Auzeloux1 & Sergio polakof  1
Blood circulation mainly aims at distributing the nutrients required for tissue metabolism and collecting 
safely the by-products of all tissues to be further metabolized or eliminated. the simultaneous study of 
arterial (A) and venous (V) specific metabolites therefore has appeared to be a more relevant approach 
to understand and study the metabolism of a given organ. We propose to implement this approach by 
applying a metabolomics (nMR) strategy on paired AV blood across the intestine and liver on high fat/
high sugar (HfHS)-fed minipigs. our objective was to unravel kinetically and sequentially the metabolic 
adaptations to early obesity/insulin resistance onset specifically on these two tissues. After two months 
of HfHS feeding our study of AV ratios of the metabolome highlighted three major features. first, the 
hepatic metabolism switched from carbohydrate to lipid utilization. Second, the energy demand of 
the intestine increased, resulting in an enhanced uptake of glutamine, glutamate, and the recruitment 
of novel energy substrates (choline and creatine). third, the uptake of methionine and threonine was 
considered to be driven by an increased intestine turnover to cope with the new high-density diet. 
finally, the unique combination of experimental data and modelling predictions suggested that HfHS 
feeding was associated with changes in tryptophan metabolism and fatty acid β-oxidation, which may 
play an important role in lipid hepatic accumulation and insulin sensitivity.
The main function of blood circulation is to provide and distribute the nutrients required for tissue metabolism 
and to collect the by-products that need to be removed from that organ and excreted safely. The modifications of 
the metabolites in the arterial and venous circulation allow to integrate the whole-body metabolism and therefore 
to maintain homeostasis. Many molecules are transported in the blood, including nutrients (amino acids, lipids, 
and carbohydrates), electrolytes and messengers (hormones, peptides, miRNA…). The composition of the blood 
passing through a tissue is therefore able to reflect its metabolic function: substances taken up by the tissue on 
a net basis will be in higher concentration in the arterial inflow than in the venous outflow, and vice et versa for 
released products. Then, for many of these substances, the circulatory system is not just a way to go in and out of 
an organ, but is also a complex system of cross-talk allowing a whole body integrative metabolism1.
Metabolomics has proved to be a valuable tool to further understand metabolic processes2. For instance, we 
and other have shown that untargeted metabolomics was particularly adapted to study the time-course adaptation 
of metabolism3–7. However, so far, the majority of the untargeted studies has focused on biomarkers discovery by 
profiling blood or urine samples8, which provides an interesting static snapshot of the whole body metabolism 
but offers limited mechanistic information. Indeed, little can be drawn from urine metabolomics about the met-
abolic activity of a particular organ. Concerning blood, venous samples, which are easily accessible and widely 
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used in clinical diagnosis, likely reflect the metabolism of a particularly-drained organ. On the contrary, arterial 
blood (exceptionally used in clinical diagnosis) is able to provide a picture of available molecules for the whole 
body metabolism as it represents the phenotype of the fluid prior to being processed by any particular organ9. The 
simultaneous study of both venous and arterial samples seems therefore a particularly relevant approach to better 
understand the metabolism a given organ. Assessment of respiratory gases, glucose and amino acids (AA) have 
been traditionally explored using the arterio-venous (AV) approach since 1930’s in order to perform fundamental 
metabolic studies at different levels (brain, splanchnic area, kidney, forearm…). However, such studies remained 
focused on a very limited and targeted set of metabolites or nutrients. Therefore, the global profile of metabolic 
utilization and exchange of metabolites and nutrients by tissues remains poorly known. In order to obtain an 
extended view of the organ metabolism beyond biomarker discovery by metabolomics, the assessment of a large 
number of metabolites in arterial and venous blood is needed. We therefore performed a global profiling of 
paired arterial and venous (portal and hepatic veins) blood, focusing on the splanchnic area (portal vein-drained 
viscera and the liver), as the central metabolic crossroad and link between absorption and intermediary metab-
olism. Samples were collected using a time-course protocol in a minipig model of obesity and insulin resistance 
(overnutrition with a high fat-high sucrose diet, HFHS)6,10 in order to challenge the metabolism with an overload 
of energy and nutrients. Blood was simultaneously drained at the fasting state before and after 7, 14, 30 and 60 
days of a HFHS diet and plasma samples were analysed by NMR-based metabolomics platform. The metabolites 
showing significant changes between venous and arterial samples were discussed in the context of the biochemi-
cal knowledge of these organs and based on the concept of arteriovenous metabostasis, as recently developed by 
Ivanisevic et al. for the study of the skeletal muscle metabolism11.
One challenge when interpreting metabolomics data is to explore the direct physiological roles of metabolites 
and their involvement in organs’ metabolic networks. Metabolic networks can provide a mechanistic context 
for understanding metabolic profiles and explore the metabolic pathways altered during the onset of obesity. 
In this study, we therefore integrated the AV metabolic profiles with Genome-Scale Metabolic Network Models 
(GSMNM) to model the global metabolism of liver and intestine. GSMNMs gather, in an organized and mathe-
matical format, all the biochemical reactions (and associated metabolites) that can occur in a given organism12. 
We used one of the most consolidated reconstruction of the human metabolic network, Recon2.0413. It includes 
more than 7700 reactions and 2600 metabolites, capturing all the reactions that can possibly occur in any human 
tissue or cell. Constraint-based modelling (CBM) methods then allow to predict the metabolic state of a tissue, by 
setting bounds (lower and upper constraints) to some specific reactions based on available experimental data14. 
In this study, constraints were set on exchange reaction fluxes in the models to enforce uptake or release of metab-
olites according to the consumption and production profiles. This modelling strategy allows contextualizing the 
generic model and generating time- and tissue-specific constrained models, which can specifically account for the 
functional metabolic network in these conditions.
Materials and Methods
Animals and experimental procedure. The study involved five female adult Yucatan mini-pigs 
(31.5 ± 1.4 kg). Three weeks before the experimentation, mini-pigs were surgically fitted with a catheter in the 
abdominal artery aorta (Art), the portal vein (PV) and the hepatic vein (HV). They were housed in subject pens 
(1 × 1.5 m) in a ventilated room with controlled temperature (21 °C) and regular light cycle (L12:D12). They were 
fed once daily with 400 g/d of a concentrate feed containing 17.5% protein, 3.2% fat, 4.3% cellulose, and 5.2% ash 
(Porcyprima; Sanders Centre Auvergne, Aigueperse, France) and had free access to tap water. All procedures were 
in accordance with the guidelines formulated by the European Community for the use of experimental animals 
(L358-86/609/EEC, Council Directive, 1986). The protocol was approved by the Ethical Committee for Animal 
Experimentation Auvergne, authorization 02090.01.
After the recovery period, minipigs were fed a HFHS diet consisting in a regular pig diet enriched with fat 
(13% palm oil) and sugar (10% sucrose) (1 kg/day, 15.5 kJ/day) for two months. Animals ingested the whole 
mixture in no more than 10 minutes. After an overnight fasting, blood was sampled through the three catheters 
simultaneously on heparinized tubes, before (d0), and 7, 14, 30, and 60 days after HFHS feeding. Blood was cen-
trifuged at 4,500 × g for 10 min, plasma rapidly collected and stored at −80 °C until further analyses. Biochemical 
and phenotype measures were also performed at the different time points: the related procedures and data have 
been previously published10.
plasma metabolomics. 200 µL of plasma samples were mixed with 500 µL of phosphate buffer (pH 7.0) 
prepared in deuterated water, and then centrifuged at 5500 g at 4 °C for 15 minutes, and 600 µL of supernatant 
were transferred to 5 mm NMR tubes. All 1H NMR spectra were obtained on a Bruker DRX-600-Avance NMR 
spectrometer operating at 600.13 MHz for 1H resonance frequency using an inverse detection 5 mm 1H-13C-15N 
cryoprobe attached to a Cryoplatform (the preamplifier unit). The 1H NMR spectra were acquired at 300 K using 
the Carr-Purcell-Meiboom-Gill (CPMG) spin-echo pulse sequence with presaturation, with a total spin-echo 
delay (2nτ) of 240 ms to attenuate broad signals from proteins and lipoproteins. A total of 256 transients were 
collected into 32k data points using a spectral width of 20 ppm, a relaxation delay of 2 s and an acquisition time 
of 1.36 s. Prior to Fourier Transformation, an exponential line broadening function of 0.3 Hz was applied to the 
FID. All NMR spectra were phased and baseline corrected, then data were reduced using AMIX (version 3.9 
Bruker, Rheinstetten, Germany) to integrate 0.01 ppm wide regions corresponding to the δ 8.6–0.7 ppm region. 
The δ 5.1–4.5 ppm region, which includes the residual water resonance, was excluded. A total of 581 NMR buckets 
were included in the data matrix. To account for differences in sample concentration, each integrated region was 
normalized to the total spectral area. For the exchange of metabolites across the organs we calculated the ratios 
between the artery and the veins: Art/PV for the intestine, and [(Art × 0.2) + (PV × 0.8)]/HV for the liver. An 
averaged relative contribution of 20% of the hepatic arterial flow (Art) to the total hepatic flow was used as an 
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approximation based on previously reported results15. We then expressed these ratios as percentage of metaboli-
sation from steady state, considering steady state as inflow/outflow = 1.
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where Art, PV and HV are the NMR integration area of each metabolite measured in plasma samples from Art, 
PV and HV respectively. For each metabolite, a signal without overlapping has been chosen for integration ratio 
calculation. %metabolisation for all measured metabolites are presented in Suppl. Fig. 1.
Statistical analyses. Multivariate analyses were used to study the effect of high fat diet along time course on 
the metabolome. Principal components analysis (PCA) was first performed to reveal intrinsic clusters and detect 
eventual outliers. Partial least squares-discriminant analysis (PLS-DA) was then used to model the relationship 
between group and spectral data. PLS-DA is similar to PCA but uses discriminant variables that correlate to 
class membership. Before analysis, orthogonal signal correction (OSC) filtering was used to remove variability 
not linked to the studied conditions (physiological, experimental or instrumental variation). Filtered data were 
mean-centered and Pareto scaled. For all the figures, Hotelling’s T2 statistics were used to construct 95% con-
fidence ellipses. The R2Y parameter represents the explained variance. Seven-fold cross validation was used to 
determine the number of latent variables to include in the PLS-DA model and to estimate the predictive ability 
(Q2 parameter) of the adjusted model. In addition, the robustness and validity of the PLS-DA models were calcu-
lated using a permutation test (number of permutations = 200). Significant NMR variables were identified using 
1D and 2D NMR spectra. Discriminated time points (i.e. with different metabolic profiles) d0, d7 and d60 were 
selected based on the multivariate statistical analyses. For these three time points, comparisons between venous 
and arterial blood across the organs were performed using t-paired Student tests and the time effect was assessed 
using a repeated-measures one-way ANOVA test. SIMCA-P software (V13, Umetrics AB, Umea, Sweden) was 
used to perform the multivariate analyses. SigmaPlot v12.3 (Systat Software, San Jose, CA) was used to perform 
the univariate analyses.
Metabolic network modelling. For each time point (d0, d7 and d60) and for each of the metabolites measured 
experimentally, paired t-tests between Art and PV and between HV and (Art × 0.2 + PV × 0.8) were performed, 
to identify metabolites significantly released or taken up by the gut or the liver. Metabolites with p-value < 0.05 
and with a metabolisation % higher than 5% were considered as taken up by the tissue, whereas metabolites with 
p-value < 0.05 and with a metabolisation % lower than −5% were considered as released. For the metabolisation 
% between −5 and +5% the metabolites were considered as not exchanged or used by the tissue. The remaining 
metabolites, with a % metabolisation lower than −5% or higher than +5% but with a p-value > 0.05, were consid-
ered as not significantly exchanged and therefore were not constrained in the modelling.
We integrated these extratissular exchange data into the GSMNM Recon216 (version 2.04, downloaded from 
http://vmh.uni.lu/#downloadview)17 to simulate metabolic fluxes through intratissular reactions and predict the 
changes in gut and liver metabolic state during HFHS feeding. The Recon2 model contains 7440 reactions and 
2626 metabolites, including 642 exchange reactions and associated metabolites which can potentially be taken 
up or secreted from the model. All these exchange reactions are initially unbounded by default (with lower and 
upper bounds set to −500 and +500 respectively), allowing uptake and secretion of all these metabolites. By 
definition of the exchange reactions in the model, a negative flux through an exchange reaction corresponds to an 
uptake of metabolite (incoming flux into the model), whereas conversely a positive flux corresponds to a release 
of metabolite (outgoing flux out of the model). Acquired metabolomics data were used to set specific constraints 
on these exchange reactions considering the metabolites evidenced as taken up, secreted and not exchanged 
from metabolomics data at each time. For released metabolites, the corresponding exchange reactions were con-
strained to enforce minimal release (i.e., minimal positive flux through exchange reaction), by setting the upper 
bound (ub) to the flux equivalent to the limit of detection (LOD) value (Suppl. Fig. 2). Similarly, for metabolites 
taken up, corresponding exchange reactions were constrained to enforce minimal negative flux through exchange 
reaction (lower bound (lb) set flux equivalent to –LOD). For metabolites considered as not exchanged (with % 
metabolisation within −5% and +5%), the corresponding exchange reactions were constrained to have a limited 
absolute flux value, lower than the LOD. Of note, contrary to not exchanged metabolites, no constraints were set 
for metabolites whose changes in level between inflow and outflow were not found to be significant (both uptake 
and release were a priori allowed). The concentration was defined as LOD in 1H NMR spectroscopy when the 
signal-to-noise ratio (S/N) of signals reached 3:1. LOD was estimated at 25 μM in NMR tube for signals corre-
sponding to 3 protons, i.e. 87.5 uM in plasma samples. LOD was estimated at 75 μM in NMR tube for signals 
corresponding to one proton, i.e. 260 μM in plasma samples. LOD, were converted to equivalent fluxes using an 
estimated blood flow value of 100 ml/g liver/h18. Constraints were set with a 20% margin from the LOD. Three 
of the experimentally exchanged metabolites (betaine, glycerophosphocholine and ethanolamine) could theo-
retically not be exchanged in the Recon2 model as they were not associated to any exchange reactions: exchange 
reactions and extracellular transport reactions were added for these metabolites to allow their import and export. 
All exchange reactions not constrained from experimental data were set to secretion only (lb = 0), except for a 
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list of metabolites which are considered as being always present in plasma and for which uptake from plasma was 
allowed in the model. A constrained model was generated for each time point and each tissue, therefore leading to 
6 time- and tissue-specific models: SI-d0, SI-d7, SI-d60, Liver-d0, Liver-d7 and Liver-d60. The list of constraints 
defined for each model in given in Suppl. Table 1.
The coefficients of the biomass reactions were adapted to better fit with the composition of an hepatic cell 
using data from the literature (Suppl. Table 2)13,19 and to account only for tissue maintenance (deoxyribonucle-
otides were excluded). Coefficients were also rescaled to get fluxes in µmol/g tissue/h instead of mmol/gDW/h 
(using an estimate of 3.8 for the liver Wet Weight (WW)/Dry Weight (DW) ratio)20. The lower bound for the 
biomass reaction was constrained in order to get a minimal protein fractional synthesis rate of 5%.h−1 21 and the 
albumin production and release was allowed in the 3 liver-specific models.
The possible range of flux values through each reaction (minimal and maximal possible fluxes) was computed 
using Flux Variability Analysis (FVA)22,23. FVA results are provided in Suppl. Table 3. To compare the simulated 
flux ranges between pairs of time points, we calculated the Jaccard distance of each reaction as the ratio of the 
intersection to the union of the flux ranges at 2 different time points. For instance, for reaction i, the Jaccard dis-
tance between simulated flux ranges at d0 ([mind0; maxd0]) and d7 ([mind7; maxd7]) is computed as follow:
=
=
−
−
−J
intersection ([min; max] , [min; max] )
union ([min; max] , [min; max] )
min(max ; max ) max(min ; min )
max(max ; max ) min(min ; min )
i,d0 d7
d0 d7
d0 d7
d0 d7 d0 d7
d0 d7 d0 d7
This represents the overlap between the possible flux values at d0 and d7: J distance of 0 indicates that the 2 
flux intervals do not overlap at all and therefore that the reaction i has distinct flux values at d0 and d7, whereas a 
J distance of 1 (100%) indicates that there is a complete overlap between possible flux values at d0 and d7.
For each pairwise time comparison and each tissue, we performed a pathway enrichment analysis on the reac-
tions with J distance lower than 1. This aims to assess whether the reactions with modulated flux values between 
2 time points are significantly over-represented in a metabolic pathway. Pathway enrichment statistics were per-
formed using one-tailed exact Fisher test, with a Bonferroni correction for multiple tests24, using the metabolic 
pathways defined in Recon2.
Results
After two months of HFHS feeding minipigs developed an obesity-like phenotype, with a significant increase in 
body weight (from 31.5 ± 1.4 kg to 44.7 ± 1.7 kg), most likely as the consequence of fat deposition at the visceral 
and subcutaneous adipose tissue6. More details about the biochemical and clinical phenotyping have been pre-
viously published10,25.
The trajectory of the metabolome obtained from different sampling sites, i.e., PV, Art and HV is shown in 
Fig. 1. Clustering of observations is very similar between the vessels. Three clusters depending on the duration 
of HFHS diet feeding were observed: d0, d7, d14 and d60. After d14, the phenotype was no longer discrimi-
nated from those of d30 or d60. In all cases, the model was valid and robust, including three latent variables, 
R² = 64.4% Q² = 0.51 for the Art; two latent variables, R² = 41.4% and Q² = 0.31 for the PV; and three latent var-
iables, R² = 64.3% and Q² = 0.47 for the HV. Because d14 and d30 were not metabolically distinct from d60, only 
d0, d7 and d60 were selected for further analyses.
Based on the results presented in the Fig. 1A, we decided to analyse separately the metabolic profiles of all 
vessels between d0 and d7, where the major shift occurred. We obtained a valid and robust model (R² = 37.4% 
and Q² = 0.32) that did not discriminate the metabolomes from the different vessel at d0 (Fig. 1B). However, at d7 
the metabolome of the PV was clearly discriminated from that of the HV and the Art. All the metabolomes at d0 
were also discriminated from those at d7.
The global profiling of inflow and outflow blood samples measured simultaneously using NMR metabolomics 
approach highlighted the significant changes in arterial vs. venous plasma during circulation across the gut and 
liver of HFHS minipigs. Based on the PLS-DA results those metabolites with significant different levels in venous 
vs. arterial plasma at d0, d7 or d60 are represented in Figs 2 and 3 (as % of metabolisation from the steady state). 
Direction of the % of metabolisation change implies either a positive AV balance, reflecting metabolite uptake by 
the organ, or a negative arteriovenous balance, reflecting metabolite release by the organ11. Among the significant 
changing metabolites, several AA were identified displaying consistently shifted ratios in time across the gut: 
higher arterial vs. venous levels were observed for glutamine (20–60% of metabolisation), glutamate (5–40% of 
metabolisation), threonine (20–30% of metabolisation, except at d0), and methionine (20–40% of metabolisation, 
except at d0), whereas increased venous levels were found for glycine (no more than −20% of metabolisation at 
d0 and 60). Several of these AA showed also modified levels between the inflow (Art and PV) and outflow (HV) 
across the liver. Opposite trend compared to gut was observed for glutamate and glycine, with a release profile 
for glutamate (−35% metabolisation) and an uptake profile for glycine (20–40% metabolisation). Higher levels of 
alanine (20–45% of metabolisation), methionine (18% of metabolisation at d0, but no metabolisation at d7 and 
d60), lysine (10% of metabolisation at d7 and 60), and phenylalanine (8% of metabolisation at d0) were found in 
the inflow plasma when compared to the outflow levels across liver.
Several metabolites directly involved in the energy flow through metabolism were also found to signifi-
cantly differ in arterial vs. venous plasma across liver, whereas no significant differences were evidenced between 
inflow and outflow across the gut (Fig. 3). Among them, several metabolites participating to the hepatic glucose 
metabolism were identified, including glucose, lactate, pyruvate and succinate. Glucose displayed higher con-
centration in outflow (hepatic vein) blood than in the inflow (arterial and portal) blood at d0 (averaging −6% 
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of metabolisation), whereas this differential release was no longer observed on d7 and d60. Inversely, lactate 
and pyruvate appeared to be released (with a −20 to −40% metabolisation) at later times only (d7 and d60). 
Succinate also showed a differential utilisation across the liver, but with a clear uptake pattern, increasing from a 
20% metabolisation at d0, up to 60% at d60. Two metabolites produced by the gut microbiota, namely acetate and 
propionate, were also identified. While for propionate the profile clearly shows an inverse pattern between gut and 
liver, with a positive balance (up to 100% metabolisation between d7-60) at the liver level and a negative balance 
(−50%) for the gut, the acetate results are less clear, with a significant negative balance evidenced only across the 
gut (averaging −50% of metabolisation) irrespectively of the day.
Other small metabolites showing significant differences between the venous and arterial blood samples were 
further identified, including betaine, ethanolamine, creatine, phosphocholine and choline (Fig. 4). While creatine 
and choline showed a clear pattern of uptake by the gut particularly significant at d60 (about 30% of metaboli-
sation), betaine showed a positive metabolisation across the liver at d7 and 60 (averaging 30%), and across the 
Artery Portal 
vein
Hepac
veinD0
D7
D14
D30
D60
Art D0
Art D7
PV D0
PV D7
HV D0
HV D7
A
B
Liver
Figure 1. (A) Scores plot of partial least squares discriminant analysis model (n = 5) after OSC filter for five 
classes: d0, d7, d14, d30 and d60 of HFHS feeding. For the artery, R² = 64.6%, Q² = 0.51; for the portal vein, 
R² = 44.4%, Q² = 0.31; for the hepatic vein, R² = 64.3%, Q² = 0.47. (B) Scores plot of partial least squares 
discriminant analysis model (n = 5) after OSC filter for six classes: artery (Art), portal vein (PV) and hepatic 
vein (HV) and d0 and d7 of HFHS feeding. R² = 37.4%, Q² = 0.32, two latent variables.
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gut (about 20% of metabolisation) at d0. Finally, we recorded a positive metabolisation across the liver at d0 for 
phosphocholine (20%) and ethanolamine (5%), along with a negative metabolisation of the latter across the gut.
Significant observed changes in metabolites levels between inflow and outflow across gut and liver were used 
to model the changes in gut and liver metabolism at d0, d7 and d60. Based on the uptake and release of metabo-
lites at each time, possible ranges for intratissular fluxes were simulated for all the reactions defined in the human 
metabolic network Recon2 (Suppl. Table 3). Changes in fluxes were compared between d0 and d7 and between d7 
and d60 for gut and liver separately. We predicted that about 100 reactions would have potentially different flux 
values between d0 and d7, but no more than 20 reactions between d7 and d60 (Suppl. Table 4). These predicted 
altered reactions between d0 and d7 mostly belong to the fatty acid oxidation pathway (Fig. 5 & Suppl. Table 5). 
Reactions involved in the tryptophan degradation pathway are also significantly present among the predicted 
changed reactions between d0 and d7 for liver, but between d7 and d60 for intestine. Also, the purine synthesis 
pathway included a significant number of predicted modulated reactions for liver (8 reactions), with a trend to 
increased possible fluxes from d0 to d7 and reduced possible fluxes from d7 to d60.
Discussion
The paired arteriovenous metabolomics data-driven study presented here provides a comprehensive over-
view of the metabolite exchange and utilization across the splanchnic area in normal and obese minipigs. 
While in previous studies single organs have been explored using this approach (muscle in healthy humans11 
and mammary gland in dairy cows26), this is the first time that such strategy is simultaneously applied to two 
organs (liver and intestine) in a pathophysiological model (obesity). Applying this AV measurement strategy 
for in vivo exploration using the obese minipig model offers two main advantages: first, to solve the problem 
of the PV access in humans27; and second, to be able to perform a follow up on the onset of obesity on the 
same individuals. We evidenced a similar metabolic trajectory in each blood vessel metabolic profile, with 
a clear discrimination of three steps: d0, d7 and d14 to d60, which is consistent with our previous study of 
the urine metabolome trajectory6. We therefore focused on the comparison of the metabolites exchanges in 
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Figure 2. Arteriovenous fold-change (A/V) across the splanchnic area (liver and portal drained viscera) of 
amino acids on five Yucatan minipigs submitted to a HFHS diet during two months. Data is presented in % 
of metabolisation (mean + sem): positive values = taken up by the organ; negative values = released by the 
organ. Based on the results obtained in the Fig. 1, only day 0, 7 and 60 are shown. Data were analysed using a 
repeated-measures one-way ANOVA test (p-value for time is shown when < 0.05). *Significantly different from 
0 (equilibrium) (P < 0.05). Different letter indicate significant differences among the days, p < 0.05.
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healthy state (d0) and in early (d7) and late (d60) obesity stages. The metabolomics data obtained across the 
intestine and the liver were also analysed by constraint-based mathematical modelling, which allowed to 
formulate further explanations about the fate of the exchanged metabolites.
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Figure 3. Arteriovenous fold-change (A/V) across the splanchnic area (liver and intestine) of energy-related 
metabolites on five Yucatan minipigs submitted to a HFHS diet during two months. Data is presented in % 
of metabolisation (mean + sem): positive values = taken up by the organ; negative values = released by the 
organ. Based on the results obtained in the Fig. 1, only day 0, 7 and 60 are shown. Data were analysed using a 
repeated-measures one-way ANOVA test (p-value for time is shown when < 0.05). *Significantly different from 
0 (equilibrium) (P < 0.05). Different letter indicate significant differences among the days, p < 0.05.
Phosphocholine
Time (days)
 0  7  60
)noitasilobate
mfo
%(
oitar
nie
V/yretr
A
-20
0
20
40
60
80
100
Intestine
Liver 
uptake
release
Ethanolamine
)noitasilobate
mfo
%(
oitar
nie
V/yretr
A
-15
-10
-5
0
5
10
15
uptake
release
*
*
Creatine
Time (days)
 0  7  60
)noitasilobate
m
%(
oitar
nie
V/yretr
A
-20
-10
0
10
20
30
40
50
uptake
release
a
a
*b
uptake
release
*
*
Choline
Time (days)
 0  7  60
)noitasilobate
mfo
%(
oitar
nie
V/yretr
A
-10
0
10
20
30
40
uptake
release
*a
*
*c
intestine, p=0.027
*
liver, p=0.054
*
Betaine
)noitasilobate
mfo
%(
oitar
nie
V/yretr
A
0
10
20
30
40
50
*
Figure 4. Arteriovenous fold-change (A/V) across the splanchnic area (liver and intestine) of metabolites on 
five Yucatan minipigs submitted to a HFHS diet during two months. Data is presented in % of metabolisation 
(mean + sem): positive values = taken up by the organ; negative values = released by the organ. Based on the 
results obtained in the Fig. 1, only day 0, 7 and 60 are shown. Data were analysed using a repeated-measures 
one-way ANOVA test (p-value for time is shown when < 0.05). *Significantly different from 0 (equilibrium) 
(P < 0.05). Different letter indicate significant differences among the days, p < 0.05.
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Characterization of the splanchnic metabolism based on the AV differences in healthy minipigs. 
At day 0 the liver metabolism shows a classical postabsorptive profile. The major role of the liver during this 
period is to provide glucose to the peripheral tissues through the de novo glucose production (gluconeogenesis)28 
(Fig. 6A). In our study, we indeed observed a negative A/V balance of glucose across the liver, demonstrating its 
hepatic production. We also observed that different substrates like lactate, pyruvate or AA29 could be delivered 
from other organs to the liver in order to produce glucose. Several gluconeogenic AA were actively taken up by 
the liver, including glycine, alanine, phenylalanine and methionine. While glycine seemed to have an intestinal 
origin, the rest of AA were most likely released from the skeletal muscle. In the particular case of alanine, its 
release from the muscle participates in the glucose-alanine cycle30 and can also explain the glutamate liver release, 
as the result of alanine transamination. Lactate and pyruvate, also tend to be taken up by the liver, which could 
contribute to the concomitant glucose output. Given that lactate was not released by the intestine, its origin would 
be likely the muscle, as previously shown in fasted pigs30 and as part of the Cori cycle.
The intestine is a metabolically active organ31: during the postabsorptive period, its AA supply comes mainly from 
the artery and is especially fueled by glutamine32 and glutamate31, which are used for energy purposes33. In our study, 
these two AA were actively taken up by the intestine, which is in agreement with the extensive glutamine utilization by 
the pig intestine31. The precise origin of glutamine could not be determined in the present study, but it would be likely 
released from the skeletal muscle30, while according to our data glutamate was rather released by the liver.
Finally, both, acetate and propionate showed a positive A/V ratio across the liver and a negative ratio across 
the intestine, reflecting their intestinal production and their hepatic uptake from the portal circulation. Acetate 
has been shown to be used as an energy substrate by the liver through its oxidation by the tricarboxylic acid cycle 
(TCA), but also as a substrate for the synthesis of cholesterol and long-chain fatty acids34. Concerning propionate, 
it is also known that the liver clears the major part of this metabolite from the portal circulation35, and that it is 
mostly used for gluconeogenesis purposes36, which is further consistent with our results.
Effects of HFHS feeding: focus on the first week. From the metabolome trajectory, we noticed that 
the phenotype of all vessels shifted a d7 (Fig. 1A). We therefore performed at this particular time a blood vessel 
comparison of the phenotype, evidencing that the metabolome of the PV is clearly discriminated from those of 
the Art and HV (Fig. 1B). Interestingly the modelling results also support this idea of a larger metabolic shift dur-
ing this first week of HFHS feeding, with a larger number of reactions having potentially modulated flux ranges 
between d0 and d7 than between d7 and d60 (Fig. 5).
In contrast to the situation observed at d0, where several metabolites involved in phospholipids metabolism 
(methionine, choline, phosphocholine and ethanolamine) were actively taken up by the liver, their uptake was 
blunted after only one week of HFHS feeding (Fig. 6B). A reduced synthesis of phospholipids could be deleterious 
for the liver, as insufficient phosphocholine supplies will inevitably cause triglyceride accumulation and eventu-
ally fatty liver37.
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Figure 5. Predicted modulated metabolic pathways. Pathway enrichment analysis showing Recon 2 pathways 
that are contain a significantly high number of reactions which predicted flux ranges differ between time points 
(as assessed by a Jaccard distance lower than 1). The size of the circles is proportional to the number of differing 
reactions. The colour of the circles depends on the p-value (one-tailed exact Fisher test, with Bonferroni 
correction for multiple tests). Pathways for which reactions tend to have a larger (resp., tighter) flux range at d7 
than d0 and at d60 than d7 are coloured in green (resp. red).
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After one week of HFHS feeding, we observed a reduced glucose release from the liver, most likely due to a 
reduced utilization of gluconeogenic substrates, like lactate and AA (methionine, phenylalanine). During the 
postabsorptive period, gluconeogenesis is predominantly fuelled by lactate38, which at d7 was no longer taken 
up by the liver, but rather released. This is also consistent with a reduction in glucose catabolism, which could 
further explain the pyruvate accumulation and release39,40. Thus, the increased availability of lipids could displace 
the use of pyruvate as a substrate for oxidative metabolism. Pyruvate will then cumulate and be subsequently 
diverted into lactate, resulting in both pyruvate and lactate release from the liver. In the same line, we observed 
that succinate was importantly taken up by the liver. In high substrate availability contexts, such as HFHS feeding, 
succinate could be released from tissues41. Under these conditions, the TCA may increase the H+ gradient over 
the mitochondrial membrane, leading to inhibition of enzymatic steps mediated by complexes within the electron 
transport chain and eventually, release of succinate into the blood stream42. In mice fed on a high fat diet and 
supplemented with sodium succinate, a reduced lipid accumulation in the liver was observed43. We may therefore 
consider that the early (d7) increased succinate uptake by the liver of the HFHS-fed minipigs could be part of a 
strategy aiming at reducing hepatic steatosis as the consequence of the deleterious fat and sugar intake. Despite a 
maintained intestinal release of acetate under HFHS feeding, its uptake by the liver was blunted after d7, which is 
consistent with the strategy to reduce lipid production from this substrate, by redirecting the intestinal acetate to 
peripheral organs for further oxidation44.
As a whole, in the first week of HFHS feeding, we observed several features suggesting that the minipig metab-
olism rapidly reprogrammed and that there might be a metabolic shift at the hepatic level toward utilizing the 
most abundant nutrients (i.e. lipids) while alleviating the potentially associated deleterious effects.
Longer-term effects of HFHS feeding. Globally the shifts observed at d7 tend to persist at d60 as sug-
gested by the fewer changes in metabolome observed between d7 and d60 (Fig. 6C). The major impact of two 
months of HFHS feeding on the intestine metabolism can be summarized by an increased energy demand coped 
by an enhanced metabolism of several metabolites. Glutamine and glutamate are the preferred substrates to fuel 
the physiological processes stimulated by the HFHS feeding, like epithelium renewal and expansion and cellu-
lar turnover45. The positive A/V balance of glutamine and glutamate is significantly increased from d0 to d60. 
Interestingly, the energy demand seems to be complemented by other metabolites poorly used at d0, like creatine, 
a major metabolite involved in energy metabolism46. Creatine could be then preferentially used to rapidly yield 
energy47, which would be consistent with the positive correlation found between the adiposity and creatine levels 
in HF-fed pigs48.
HFHS consumption may induce cellular stress and inflammation at the intestinal level49. Some metabolic fea-
tures observed in this study are consistent with this hypothesis and could be related to biological processes aiming 
at developing the intestinal functionality. For instance, methionine and threonine were more highly taken up after 
two months of HFHS consumption. This is consistent with the fact that methionine participates in the epithelial 
cell turnover as well as in the maintenance of the antioxidant status (by keeping cysteine available) and the cell 
level of reduced glutathione50, while threonine is largely used for mucins synthesis in pig mucosa51,52, which is of 
outmost importance in epithelium protection and innate immune defence.
In parallel, we also reported that glutamate A/V across the liver was further increased at d60, suggesting its 
larger exportation into the peripheral circulation. Barber et al. reported that in cafeteria-fed animals glutamate 
was released from the liver while urea production was reduced53, which is consistent with our previous observa-
tions6 and could reflect a nitrogen sparing mechanism already observed in other situations54,55. We may therefore 
suggest that these changes would result from a metabolic switch in which AA catabolism would be reduced in 
detriment of lipids utilization, highly abundant in the HFHS diet, and able to induced a reduction in the urea 
cycle in both rodents53,56 and pigs10.
Splanchnic metabolism in obese HFHS-fed minipigs: insights from mathematical modelling. 
In order to go deeper into the exploration of the changes in splanchnic metabolism under HFHS feeding, we have 
submitted the AV metabolomics data to constraint-based mathematical modelling. Our results allowed gaining 
new insights into the intrahepatic routing of exchanged metabolites experimentally assessed by NMR and mainly 
predicted changes in three metabolic pathways: fatty acid oxidation, tryptophan metabolism and purine synthesis 
(Fig. 5).
Our in silico simulations predicted that the metabolic fluxes through the tryptophan pathway reactions tend 
to be increased towards the production of kynurenine and its downstream metabolites, some of them (like 
3-hydroxy-kynurenine, 2-Amino-3-carboxymuconate semialdehyde) being major crossroads for the produc-
tion of kynurenate, xanthunerate or quinolenate57. These metabolites were shown to be elevated in obese and 
insulin resistant subjects, and some of the metabolites participating at these particular pathways are known to 
reduce insulin production and sensitivity in laboratory animals58,59. Further, changes in tryptophan and its related 
metabolites have been associated with altered indoleamine 2,3-dioxygenase-1 activities, one of the rate-limiting 
enzyme of tryptophan catabolism and a possible indirect indicator of immune mediated inflammation in obese 
and overweight conditions60,61.
We also predicted that the activity of the purine synthesis pathway would be transitory increased in liver after 
7 days of HFHS diet, with a potentially larger flux through a set of reactions belonging to this pathway at d7. This 
temporary shift might be linked to a possible higher hepatic uptake of glutamine, which is used as a co-substrate 
for some reactions in the pathway, at d7.
Simulations based on the metabolomics data also predicted modulations in the fatty acid oxidation pathway, 
with smaller fluxes through about 60 fatty acid mitochondrial β-oxidation reactions, which is in line with our pre-
vious study showing a reduced expression level of limiting enzymes of this pathway25. The reactions predicted to 
be modulated are specifically those relying on FAD as co-factor. The fact that betaine became significantly taken 
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up at d7 and d60 and that its metabolism also consumes FAD could therefore be linked with the reduction of the 
fatty acid β-oxidation pathway as a result of FAD competition between reactions.
It should be noted, that one limit of the modelling approach is that the predictions highly depends on the 
metabolic network model used as a basis: in this study, because there is currently no manually curated, and 
therefore reliable, reconstruction for the metabolic network of the minipig, or even the pig, we chose to use one of 
the most up-to-date and consolidated reconstruction of the human metabolic network, Recon2.04. Also, we use 
the global human metabolic model rather than tissue-specific models since we wanted to be able to compare the 
analyses made from the metabolomics data obtained both for the liver and intestine. Despite this, it is interesting 
to notice that the pathways pointed out by the modelling are different from those identified when looking directly 
at the metabolomics data. By considering the metabolic network and all the interconnections between the met-
abolic reactions, we are able to predict changes in metabolic pathways that could be the indirect consequence of 
a differential use of external metabolites. Therefore, we provided strong cues that this modelling approach based 
on the metabolic network is useful to suggest new and complementary pathways that could not be evidenced by 
looking directly at the data and would be a helpful tool when digging further into the mechanisms of the observed 
changes.
conclusions and perspectives. Overall, our time-course study of the paired arterial and venous metabo-
lomes across the intestine and liver of HFHS-fed minipigs provided original information about the subtle meta-
bolic regulation taking place during the onset of obesity and insulin resistance10,25. Further, our high-throughput 
approach allowed reflecting the metabolic activity of these organs by providing unique information that could not 
be obtained by a single venous sampling.
Our approach allowed characterizing the splanchnic area metabolism on healthy minipigs (Fig. 6), including 
the major role of the liver at the postabsorptive state as supplier of glucose to the peripheral organs, such as the 
intestine. This glucose output is thought to be fed by different substrates, including muscle-derived lactate and 
alanine, but also intestinal AA. Finally, we reported that in the absence of luminal nutrients, the intestine was 
largely taking up glutamine and glutamate, its preferred energy substrates, most likely from muscular and hepatic 
sources respectively. After two months of HFHS feeding and obesity onset, our study of A/V ratios of the metab-
olome highlighted three major features: first, the hepatic metabolism shifted from carbohydrate to lipid utiliza-
tion; second, the energy demand of the intestine increased, resulting in an enhanced uptake of already (d0) used 
metabolites (glutamine, glutamate), and the recruitment of novel (d7) energy substrates, like choline and creatine; 
third, other metabolic changes, like the uptake of methionine and threonine were considered to be driven by an 
increased intestine turnover and epithelium development to cope with a new diet rich in energy and nutrients. 
Eventually, the unique combination of experimental and modelling-derived data suggested that HFHS feeding 
would be indirectly associated with modulations of original metabolic pathways, such tryptophan metabolism 
and fatty acid mitochondrial beta-oxidation, which may play an important role on lipid hepatic accumulation and 
whole-body insulin sensitivity.
Data Availability
All data generated or analysed during this study are included in this published article (and its Supplementary 
Information files). Other datasets generated during and/or analysed during the current study are available from 
the corresponding author on reasonable request.
Metabolomics data will be available on the MetaboliLights platform upon acceptance of the article.
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Figure 6. Schematic representation of the main biochemical reactions observed across the splanchnic area 
(intestine and liver) in HFHS-fed minipigs for 3 different stages in the onset of obesity. Exchange fluxes 
represented in the figure are based on the inflow to outflow ratios measured by NMR and the modelling results. 
Acet, acetate; Ala, alanine; Bet, betaine; Gln, glutamine; Gluc, glucose; Glu, glutamate; Gly, glycine; Kynu, 
kynurenine; Lac, lactate; OAA, oxaloacetate; Phe, phenylalanine; Pyr, pyruvate; sarco, sarcosine; Thr, threonine; 
Trp, tryptophan; Xanth ac, xanthurenic acid.
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